Anti-EphB1+EphB2+EphB3+EphB4, ALEXA Fluor 594
GENTObs-7045R-A594
100 microliters
489 EUR
N/A
N/A
None
2047
IF(IHC-P)
1ug per 1ul
590nm/617nm
Alexa conjugate 1
ALEXA FLUOR® 594
IF(IHC-P)(1:50-200)
Polyclonal Antibody
Human (Homo sapiens)
Polyclonal Antibodies
Purified by Protein A.
EphB1+EphB2+EphB3+EphB4
Conjugated Primary Antibody
Anti-EphB1+EphB2+EphB3+EphB4
Alexa Fluor,ALEXA FLUOR® 594
Rabbit (Oryctolagus cuniculus)
EphB1+EphB2+EphB3+EphB4 Antibody
For facs or microscopy Alexa 1 conjugate.
No modification has been applied to this antibody
This antibody reacts specifically with EphB1+EphB2+EphB3+EphB4
KLH conjugated synthetic peptide derived from human EphB1+EphB2+EphB3+EphB4
Water buffered solution containing 100ug/ml BSA, 50% glycerol and 0.09% sodium azide. Store at 4°C for 12 months.
This antibody needs to be stored at + 4°C in a fridge short term in a concentrated dilution. Freeze thaw will destroy a percentage in every cycle and should be avoided.
No significant cross reactivity has been observed for this antibody for the tested species. However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species.
Receptor for members of the ephrin-B family. Binds to ephrin-B1, -B2 and -B3. Binding with the guidance cue ephrin-B2 at the optic chiasm midline redirect ventrotemporal (VT) retinal ganglion cells (RGCs) axons ipsilaterally. May be involved in cell-cell interactions in the nervous system.
Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody, thus reducing its reactivity, specificity and sensitivity. For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube. Prior to use briefly centrifuge the vial to gather all the solution on the bottom.
CAPB;DRT;EK2;EK5;EK6;ELK;elk related tyrosine kinase;EPH like kinase 2;EPH like kinase 6;EPH like tyrosine kinase 2;eph tyrosine kinase 2;eph tyrosine kinase 3;EPH-like kinase 6;Ephb1;EPHB1_HUMAN;EPHB2;EPHB3;EPHB4;ephrin receptor EphB4;ephrin type B receptor 1;ephrin type B receptor 2;ephrin type B receptor 3;ephrin type B receptor 4;Ephrin type-B receptor 1;EPHT2;EPHT3;ERK;ETK2;Hek 5;Hek 6;HEK2;HEK5;HEK6;hepatoma transmembrane kinase;HTK;human embryo kinase 2;MYK1;NET;PCBC;protein tyrosine kinase HEK5;renal carcinoma antigen NY REN 47;soluble EPHB1 variant 1;soluble EPHB4 variant 1;soluble EPHB4 variant 2;soluble EPHB4 variant 3;TYRO11;Tyro5;TYRO6;tyrosine protein kinase receptor EPH 2;tyrosine protein kinase receptor EPH 3;tyrosine protein kinase receptor EPH2;tyrosine protein kinase receptor EPH3;tyrosine protein kinase receptor HTK;tyrosine protein kinase TYRO11;tyrosine protein kinase TYRO5;tyrosine protein kinase TYRO6;Tyrosine-protein kinase receptor EPH-2.